Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
China SXT Pharmaceuticals, Inc. (SXTC) had Cash Flow from Financial Activities of $14.43M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$34.51M |
|
$2.74M |
|
$2.74M |
|
$34.76M |
|
$4.35M |
|
$0.64M |
|
$0.64M |
|
$5.05M |
|
$29.71M |
|
$29.70M |
|
$29.71M |
|
-- |
|
| Cash Flow Statement Financials | |
$-4.02M |
|
$-1.25M |
|
|
Cash Flow from Financial Activities |
$14.43M |
$18.13M |
|
$28.18M |
|
$10.05M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|